Evangelia-ourania O. Fourkala

London, ENG WC1E6BT, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

Colorectal cancer ascertainment through cancer registries, hospital episode statistics, and self-reporting compared to confirmation by clinician: A cohort study nested within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).

Colorectal cancer ascertainment through cancer registries, hospital episode statistics, and self-reporting compared to confirmation by clinician: A cohort study nested within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).

Journal: Cancer epidemiology
Published: March 28, 2018

Aberrant regulation of RANKL/OPG in women at high risk of developing breast cancer.

Aberrant regulation of RANKL/OPG in women at high risk of developing breast cancer.

Journal: Oncotarget
Published: October 10, 2016

Corrigendum to "Sex hormone measurements using mass spectrometry and sensitive extraction radioimmunoassay and risk of estrogen receptor negative and positive breast cancer: Case control study in UK Collaborative Cancer Trial of Ovarian Cancer Screening (UKCTOCS)" [Steroids 110 (2016) 62-69].

Corrigendum to "Sex hormone measurements using mass spectrometry and sensitive extraction radioimmunoassay and risk of estrogen receptor negative and positive breast cancer: Case control study in UK Collaborative Cancer Trial of Ovarian Cancer Screening (UKCTOCS)" [Steroids 110 (2016) 62-69].

Journal: Steroids
Published: August 14, 2016

Novel risk models for early detection and screening of ovarian cancer.

Novel risk models for early detection and screening of ovarian cancer.

Journal: Oncotarget
Published: August 05, 2016

Sex hormone measurements using mass spectrometry and sensitive extraction radioimmunoassay and risk of estrogen receptor negative and positive breast cancer: Case control study in UK Collaborative Cancer Trial of Ovarian Cancer Screening (UKCTOCS).

Sex hormone measurements using mass spectrometry and sensitive extraction radioimmunoassay and risk of estrogen receptor negative and positive breast cancer: Case control study in UK Collaborative Cancer Trial of Ovarian Cancer Screening (UKCTOCS).

Journal: Steroids
Published: October 27, 2015

Protein Z: A putative novel biomarker for early detection of ovarian cancer.

Protein Z: A putative novel biomarker for early detection of ovarian cancer.

Journal: International journal of cancer
Published: September 03, 2015

Association of skirt size and postmenopausal breast cancer risk in older women: a cohort study within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).

Association of skirt size and postmenopausal breast cancer risk in older women: a cohort study within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).

Journal: BMJ open
Published: September 26, 2014

Steroid hormone measurements from different types of assays in relation to body mass index and breast cancer risk in postmenopausal women: Reanalysis of eighteen prospective studies.

Steroid hormone measurements from different types of assays in relation to body mass index and breast cancer risk in postmenopausal women: Reanalysis of eighteen prospective studies.

Journal: Steroids
Published: August 05, 2014

Serum CA19-9 is significantly upregulated up to 2 years before diagnosis with pancreatic cancer: implications for early disease detection.

Serum CA19-9 is significantly upregulated up to 2 years before diagnosis with pancreatic cancer: implications for early disease detection.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 19, 2014

Discovery of serum biomarkers of ovarian cancer using complementary proteomic profiling strategies.

Discovery of serum biomarkers of ovarian cancer using complementary proteomic profiling strategies.

Journal: Proteomics. Clinical applications
Published: June 17, 2014

Identifying hopelessness in population research: a validation study of two brief measures of hopelessness.

Identifying hopelessness in population research: a validation study of two brief measures of hopelessness.

Journal: BMJ open
Published: June 01, 2014

A BRCA1-mutation associated DNA methylation signature in blood cells predicts sporadic breast cancer incidence and survival.

A BRCA1-mutation associated DNA methylation signature in blood cells predicts sporadic breast cancer incidence and survival.

Journal: Genome medicine
Published: March 25, 2014
Showing 1-12 of 16

Last Updated: 09/26/2026